Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 2, 2011

Primary Completion Date

May 6, 2020

Study Completion Date

May 5, 2021

Conditions
Children and Adolescent With Type 2 Diabetes
Interventions
DRUG

Exenatide Once Weekly

2 mg exenatide once weekly

DRUG

Placebo

Placebo

Trial Locations (35)

1023

Research Site, Budapest

1083

Research Site, Budapest

1094

Research Site, Budapest

1180

Research Site, Kuwait City

5400

Research Site, Sevlievo

5800

Research Site, Pleven

6500

Research Site, Baja

6725

Research Site, Szeged

14222

Research Site, Buffalo

20016

Research Site, Aguascalientes

27599

Research Site, Chapel Hill

28205

Research Site, Charlotte

31096

Research Site, Haifa

34000

Research Site, Durango

37232

Research Site, Nashville

40202

Research Site, Louisville

44106

Research Site, Cleveland

44130

Research Site, Guadalajara

52242

Research Site, Iowa City

57701

Research Site, Rapid City

58001

Research Site, Chernivts?

61002

Research Site, Kharkiv Region

64111

Research Site, Kansas City

65031

Research Site, Odesa

73104

Research Site, Oklahoma City

75390

Research Site, Dallas

76014

Research Site, Ivano-Frankivsk

77030

Research Site, Houston

84101

Research Site, Beersheba

90078

Research Site, Los Angeles

91910

Research Site, Veracruz

5265601

Research Site, Ramat Gan

06511

Research Site, New Haven

02115

Research Site, Boston

39216-4505

Research Site, Jackson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY